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Gregory A. Petsko is Gyula and
Katica Tauber Professor of
Biochemistry and Chemistry and
Director of the Rosenstiel Basic
Medical Sciences Research Center
at Brandeis University. He did his
undergraduate work at Princeton
and his graduate work as a Rhodes
Scholar at Oxford University. He
held faculty positions at Wayne
State University School of
Medicine and MIT before moving
to Brandeis in 1990. A structural
biologist, he is best known for his
work, together with his colleague
Dagmar Ringe, on the structural
basis of enzyme catalytic power
and the role of protein dynamics in
protein function. He writes a
regular opinion column for the
journal Genome Biology.
What turned you on to biology in
the first place? Two courses I
took at Princeton as an
undergraduate trying to decide
between going on in classical
literature or switching to chemistry.
A graduate course in biochemistry
from Bruce Alberts and a graduate
course in molecular biology from
Robert Langridge opened my eyes
to the enormous number of
fascinating and important
questions in biology that could be
addressed from a chemical
perspective. I’ve always
encouraged undergraduates to
take graduate level courses
because of that experience: upper
level courses offer a more realistic
perspective of what’s going on in a
field than lower level survey
courses. 
Do you have a favourite paper?
Several. Just about any paper by
David Phillips, Chris Walsh or
Jeremy Knowles, for their
combination of style and
substance. Unlike most scientific
papers, theirs are written with
verve and clarity, sometimes a dry
wit, and always an appreciation for
the power of language. I’m also a
big fan of the old literature —
anything prior to about 1965. We’re
so dependent on technology now,
and so pressured to crank out
data, that we sometimes forget
how to think deeply about
problems and extract the most
from our observations. Scientists
who worked before the
technological revolution in biology
really knew how to analyse data,
and the best of them were capable
of drawing penetrating conclusions
by careful and thorough reasoning.
Their papers are an advanced
course in scientific reasoning and a
joy to read as well. For
biochemists, I’d recommend any of
the early papers of the late Robert
Abeles as good examples of this. 
What is the best advice you’ve
been given? When I was a junior
faculty member at Wayne State
Medical School in Detroit, Richard
Hudson told me to forget about
trying to get to a better place and
concentrate on doing the best
work I could; that if I did,
opportunities to move on would
come of their own accord. I tried to
follow his advice and four years
later I was offered jobs at UCSF
and MIT (I took the latter one). The
best advice I can give someone
wondering whether to start a
career in biology would be to
follow your passion wherever it
leads you: choose your field and
your problems because they excite
you, because you want more than
anything else in the world to find
out the answers.
What is your favourite
conference? My favourites are the
Gordon Conferences. I love their
mixture of senior and junior people,
the informality of the setting, the
tradition of people presenting their
newest results, and the
opportunities for real interaction.
Surprisingly, I also like large,
general meetings like the
ASBMB/FASEB conferences: I
never attend talks in my own field;
instead, I go to talks in fields I
know nothing about. It’s a great
way to broaden one’s background,
and you can walk out of a bad talk
without offending anyone you
know!
Do you have a scientific hero?
Again, several. To avoid
embarrassing anyone, I’ll stick to
the deceased. David Phillips first
and foremost, my Ph.D. supervisor.
He was my scientific father, and
one of my best friends ever. The
quality of his work was always of
the highest; his clarity of thought
was breathtaking; and his
character was admirable in every
sense of the word. He was the first
to solve the structure of an enzyme,
and despite having little formal
training in chemistry he made
profound insights into the nature of
chemical catalysis that have stood
for over 40 years. One of the many
things he taught me was to strive
for clarity of both thought and
expression — they feed on each
other. I have to mention also two
people with whom I did advanced
training, Pierre Douzou and Ira
Herskowitz, for their informal,
inclusive and warm style.
What do you think about the
‘electronic revolution’ and the
push for free access to papers? I
support it so strongly that I’m on
the editorial board of the Public
Library of Science and also a
member of the editorial board for
the open access Journal of
Biology. I like the idea of authors
owning the rights to the material in
their own papers, and making that
material freely available for any
reasonable use by others. That
seems to me to be in keeping with
the spirit of science. I have no
objections to publishers making
money — they still will in this
model — but the present system
seems to me to restrict access to
information too much, especially
for people in third world countries.
Open access will only work,
though, if the best people in the
field choose to publish their best
work this way. Funding agencies
must provide support for scientists
to buy into open access publishing;
and grant review bodies and tenure
and promotion committees must
get away from the Nature-Science-
Cell mindset about where one has
to publish in order to succeed.
What do you think are the big
questions to be answered next
in your field? I work in several
different areas, and yet oddly I
think the answer is somewhat
similar for each. In structural
biology, it’s how to integrate
structural information obtained for
molecules in isolation into the
complex networks of interacting
molecules that we know occur in
living cells. That’s going to require
a level of understanding of the
relationship between structure and
function we don’t yet possess. In
enzymology, I think it’s how to
move from an understanding of
enzyme kinetics, regulation and
mechanism in vitro, where protein
concentrations tend to be low
relative to substrate
concentrations, to an
understanding of enzyme
behaviour in vivo, where just the
opposite is true. I suspect that for
almost any branch of biology these
days, the Next Big Thing is going
to be to obtain a better sense of
what really goes on inside the cell
or organism. Most of us have been
reductionists for most of our
scientific lives, and that’s still a
powerful approach, but we’re
going to have to start being more
holistic in our thinking.
What is the biggest challenge to
the scientific community in the
short term? I think it’s how to
balance the competing needs for
increased security and openness,
especially in biology. The threat of
bioterrorism is being used as an
excuse by governments to assert a
degree of control over the flow of
information that is potentially
threatening, not only to scientific
progress but to individual liberty.
Yet I believe we can’t ignore the
fear the public has about some of
the things we have created and are
capable of creating. My feeling is
that we ought, as a community, to
impose a limited number of
voluntary restrictions on ourselves
to forestall more draconian actions
by governments, and to reassure
an increasingly anxious lay public.
The biggest challenge in the
medium and long term may well be
to restore public trust in science as
an institution. Our commercial
flirtations have eroded a lot of that
trust; bioterrorism hasn’t helped
any. And this age seems to me to
be drifting towards anti-
intellectualism, religious
fundamentalism and suspicion of
the scientific approach to the
world. We have been too hesitant
as a community, I think, to engage
the forces promoting creationism,
‘intelligent design’ and other anti-
science doctrines in the kind of
vigorous debate that is needed. If
we’re not careful, we’ll lose the
argument by default.
What was your best moment as
a scientist? That’s easy:
September 4, 1980, the day
Dagmar Ringe first walked into my
office at MIT. I was sitting in the
basement of Building 18, a
beginning associate professor in
the chemistry department, when
there was a knock on my door.
Dagmar, who at that time had a
part-time appointment running the
undergraduate chemistry labs,
stepped in and asked if she could
learn protein crystallography by
working with me. She had studied
enzyme kinetics but essentially
dropped out of research for ten
years to raise two children by
herself. Now she wanted to get
back into it and thought that a
structural approach was the way to
go. That was more than twenty
years ago. She learned protein
crystallography very quickly and
for almost nine years, working
whenever she could find the time
while still running the
undergraduate labs, managed to
do such beautiful work that her
first full-time academic
appointment was as a tenured
faculty member in the
Biochemistry Department at
Brandeis University. She is the
finest scientist I ever worked with.
For 23 years we’ve worked as a
team, sharing equipment, often
students and projects. About half
of all we do we do jointly. Our
groups meet as one. Our students
have two faculty members to go to
for advice and for
recommendations and support
after they move on. Nearly all of
the work I’m best-known for, and
all of the work of which I am most
proud, is at least as much hers as
mine. I think this is a wonderful
way to work. What can be a lonely
business is never lonely for me.
You like to teach
undergraduates: what is the
biggest need in science
education today? At the university
level, it’s how to make the lowest
level science courses convey the
excitement of what scientists are
really interested in now. Most basic
science courses are not only dull,
they’re fifty years out of date.
Chemistry is particularly bad in this
regard. Basic chemistry courses
hardly touch on organic, or
biological chemistry or materials
science, which is where the most
interesting work is going on right
now. The whole undergraduate
chemistry curriculum should be
blown up and created anew. 
Finally, what do you think will
be the likely impact of ‘big’
biology? Biology has changed
forever. It used to be a place where
people could escape the
quantitative sciences. But like all
maturing disciplines, it is becoming
more quantitative, more
computational all the time and the
trend to ‘big’ biology is
accelerating that transition. ‘Big’
biology produces lots of data, and
data have to be analysed. ‘Big’
biology is also as much an
engineering science as it is a life
science in many ways. If we want
to assess the impact of these
trends, just look at other, more
mature subjects where it has
already happened. It happened in
physics, for example. Cutting-edge
work in many areas of physics is
now done by huge interdisciplinary
teams using big, expensive
instruments; it’s almost as much
an engineering and mathematical
science as it is ‘physics’. Look at
physics and you will see the likely
future of a big chunk of biology.
And yet, there is still room in some
areas of physics for small labs and
individual-investigator-driven
science. I think that will be true in
biology too. I hope so, and hope
we never cease to regard that kind
of work as being at least equally
important. The ability to satisfy
individual curiosity, to gratify one’s
passion to explore an area just
because it seems interesting, is
what makes being a scientist a
great life. I’ve certainly had a
wonderful time, and I’d
recommend it to anyone who
wants to do something that is
absorbing, enjoyable and
worthwhile. 
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